Shifting cell death modes in hepatic steatosis: from apoptosis to necroptosis
Open Access
- 1 January 2026
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 73 (1) , 13-20
Abstract
In the liver, hepatocyte death occurs during the regeneration process following injury. While hepatocyte death triggers regeneration through hepatocyte proliferation in the non-steatotic liver, it impairs this process in the steatotic liver. Both the number and mode of hepatocyte death during regeneration change in the steatotic liver, affecting regeneration and thereby contributing to the progression of acute liver injury and metabolic dysfunction-associated steatotic liver disease (MASLD). Apoptosis, a non-inflammatory mode of cell death, predominantly occurs during liver regeneration. As hepatic steatosis progresses, sporadic and scattered apoptotic cell death increases, leading to delayed regeneration. In severe steatotic livers undergoing regeneration, the mode of cell death shifts to pro-inflammatory necroptosis. This transition leads to inflammation around the dead hepatocytes, resulting in zonal hepatocyte death and further impairing regeneration, thus exacerbating acute liver injury and MASLD. The integrated stress response (ISR), mediated by phosphorylation of the α-subunit of eukaryotic initiation factor 2 (eIF2α), plays a crucial role in regulating hepatocyte death during steatotic liver regeneration. The ISR-induced transcription factor C/EBP homologous protein (CHOP) promotes apoptosis, thereby delaying regeneration. When ISR is further enhanced, activating transcription factor 3 (ATF3) is upregulated, inducing the expression of receptor-interacting protein kinase 3 (RIPK3), which shifts cell death mode from apoptosis to necroptosis. While treatments for MASLD targeting apoptosis have shown limited success, future therapies targeting necroptosis and its regulatory molecules may provide novel therapeutic strategies.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP23H03306)
- Japan Society for the Promotion of Science (JP22H03507)
- Japan Society for the Promotion of Science (23K24764)
- Japan Society for the Promotion of Science (25K03060)
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Eli Lilly Japan
- Japan Agency for Medical Research and Development (JP23gm6910002)
- Japan Science and Technology Agency (JPMJCR2123)
This publication has 57 references indexed in Scilit:
- Understanding the marvels behind liver regenerationWIREs Developmental Biology, 2019
- The Dynamics of Apoptotic Cell ClearanceDevelopmental Cell, 2016
- Receptor interacting protein 3 protects mice from high‐fat diet‐induced liver injuryHepatology, 2016
- Growth arrest and DNA damage‐inducible 34 regulates liver regeneration in hepatic steatosis in miceHepatology, 2014
- ER stress-induced cell death mechanismsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in miceHepatology, 2013
- Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injuryHepatology, 2012
- ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytesJournal of Hepatology, 2011
- Secondary necrosis: The natural outcome of the complete apoptotic programFEBS Letters, 2010
- Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic SteatohepatitisHepatology, 2009